FGF1 and intrahepatic cholangiocarcinoma: FGFR inhibitor AP24534 could suppress FGF1‐induced expression of Slug and Snail, and rescue the decrease in E‐cadherin, indicating AP24534 could attenuate the FGF1‐induced EMT process of ICC (Figure 5E).